Search Results for: lawsuits

Intellicell Inspected By FDA: What Does It Mean?

IntelliCell (SVFC) is a stem cell company that does cosmetic stem cell procedures. They’ve had a number of challenges of late including an FDA warning letter about a year ago and apparent financial issues manifesting in lawsuits. Now the company itself, perhaps trying to get ahead of the news, issued a press release (PR) saying they …

Intellicell Inspected By FDA: What Does It Mean? Read More »

Stem cell company Intellicell facing new financial wrinkles

Intellicell

It’s difficult to make it as a biotech company, I would say stem cell biotechs in general may have an even rougher time, and one such company,  Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my opinion. An online financial tool predicts the probability of companies going bankrupt within the next …

Stem cell company Intellicell facing new financial wrinkles Read More »

Texas Judge Issues Complicated Restraining Order in Celltex v. RNL Bio/Human Biostar tussle

Today, a judge issued a complex, temporary restraining order (PDF here, provided by Celltex) regarding Texas stem cell company Celltex and Human Biostar Inc (HBI)/Biostar, former partners who are now in conflict and have sued each other. For more background see here, here, and here. Note that while both parties have sued each other, the judge’s ruling …

Texas Judge Issues Complicated Restraining Order in Celltex v. RNL Bio/Human Biostar tussle Read More »

Celltex and former partner RNL Bio/Biostar sue each other: what’s going on?

Celltex is a stem cell company in Texas most well known for Guv Rick Perry’s stem cell transplant. The Celltex business model is to isolate, amplify, and bank patients’ stem cells for subsequent treatment by physicians (for more background including on the FDA role see here and here). Until the last few weeks, an important element …

Celltex and former partner RNL Bio/Biostar sue each other: what’s going on? Read More »

Surprising main obstacle to point-of-care stem cell commercialization by small clinics

There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically …

Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »

Testimony in supermodel stem cell fraud case: “I lied to patients”

“I lied to patients,” testified a weeping, young woman in court related to a fraud allegation involving stem cells. She had worked as an office assistant at a company that injected bogus and potentially dangerous cow-based “stem cell” treatments into human patients. This company, which in different incarnations went by various names including Biomark in …

Testimony in supermodel stem cell fraud case: “I lied to patients” Read More »

The anti-cure movement continues attacks on stem cell research, this time in Missouri

The opponents of hope, those anti-cure crusaders, will not give up and they are active on both the state and federal levels. Today we heard from the S. Louis Beacon that “Missouri Roundtable for Life” is aiming for a 2012 ballot initiative to change the definition of human cloning in such a way that some forms …

The anti-cure movement continues attacks on stem cell research, this time in Missouri Read More »

Stem cell tourism: from bad to worse from 2010-2011

350_Irv1

At last year’s ISSCR 2010 Meeting in San Francisco, President Irv Weissman talked about the dangers of unvalidated stem cell treatments. He talked about the responsibility of stem cell scientists to stand against these and the importance for scientists not to endorse or serve on advisory committees of companies peddling such products and “therapies”. As …

Stem cell tourism: from bad to worse from 2010-2011 Read More »

Victory for science and patients: what the appeals court ES cell ruling means (UPDATE)

judge-royce-lamberth

A Federal Appeals Court ruled 2-1 today to overturn Judge Lamberth’s injunction against federal funding of ES cell research. Great news! You can read the decision here (warning: big pdf). A key part of the ruling was the following: “the plaintiffs are unlikely to prevail because Dickey-Wicker is ambiguous and the NIH seems reasonably to …

Victory for science and patients: what the appeals court ES cell ruling means (UPDATE) Read More »